Erika B-Cure Laser Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCUR.TA research report →
Price Chart
About the company
Erika B-Cure Laser Ltd, established in Haifa, Israel in 2007, is a company dedicated to the full lifecycle of its B-Cure laser product line, from development and manufacturing to global marketing, sales, and distribution. Formerly known as Erica Carmel Ltd until its rebranding in January 2022, the company offers a diverse array of laser devices tailored for various therapeutic applications in both domestic and international markets. Their product portfolio includes: The B-Cure Laser Classic, a medical device for home use that addresses a broad spectrum of conditions including general pain, orthopedic issues, dermatological problems, inflammation, and supports wound healing.
- CEO
- Ronen Goldstein
- IPO
- 2021
- Employees
- 40
- HQ
- Haifa, IL
Get TickerSpark's AI analysis on BCUR.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $17.50M
- P/E
- -3.71
- PEG
- 0.03
- P/S
- 0.54
- P/B
- 2.07
- EV/EBITDA
- -6.47
- Div Yield
- 0.00%
- Gross Margin
- 69.29%
- Op Margin
- -11.83%
- Net Margin
- -15.67%
- ROE
- -50.48%
- ROIC
- -33.03%
Latest fiscal year · YoY change
- Revenue
- $37.96M+27.0%
- Gross Profit
- $26.05M+13.3%
- Op Income
- $-9,927,000
- Net Income
- $-9,470,000+50.7%
- EPS
- $-0.09+49.4%
- OCF Growth
- +52.9%
- FCF Growth
- +53.3%
- 52W High
- $30.30
- 52W Low
- $15.00
- 50D MA
- $22.92
- 200D MA
- $22.48
- Beta
- 1.20
- RSI (14)
- 51
- Avg Volume
- 56.16K
No earnings-call transcripts are available for BCUR.TA yet.
- Free Float
- 20.8%
- Shares Outstanding
- 104.17M
- Float Shares
- 21.64M
Our BCUR.TA coverage
Recent articles, reports, and earnings notes.
No research on BCUR.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BCUR.TA report →